<i id='BD03DB6350'><strike id='BD03DB6350'><tt id='BD03DB6350'><pre id='BD03DB6350'></pre></tt></strike></i> 
WASHINGTON — Former President Trump is back to campaigning for tying Medicare drug prices to lower prices abroad.
In Trump fashion, he claimed in a video announcement this month that he is the “only president in modern times” to take on the drug industry — and dinged President Biden directly.
advertisement
“Biden canceled my tough-on-pharma policies the moment he had a chance,” Trump said.
Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!
GET STARTED Log In
Wildfire smoke exposes gaps in outdoor worker protections 
ASCO: AstraZeneca's hat trick, and palliative care's spotlight 
New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum 
ASCO 2024: 'Reassuring' Corbus data on ADC bladder cancer drug 
Psychedelics group wrestles with new pharma identity 
At ASCO, AstraZeneca reports strong data for breast cancer drug 
Moonlake's readout produced a cash windfall. Risks remain 
ASCO: AstraZeneca says CAR 
The high cost of giving birth even with insurance 
Letters to First Opinion on caregivers, digital health, and more 
Dobbs anniversary: the lost opportunity of abortion as health care 
Ionis drug prevents swelling attacks due to hereditary angioedema 
Biden outlines 'new path' to provide student loan relief after Supreme Court rejection 
Innovation in antibiotics is ailing. 'Brain drain' may kill it 
FDA approval of Sarepta Duchenne genetic therapy gives me hope 
